OSE Immunotherapeutics Unveils 2026–2028 Strategic Plan With Four Opportunities for Value Creation Completion of Tedopi’s phase 3 in Non-Small Cell Lung Cancer One or two new rare/specialty ...

The pharmaceutical supply chain and device development have become intricately linked. Harmonizing formulation development ...

BEIJING, Dec 8 (Xinhua/APP): The National Language Resources Monitoring and Research Center announced the top 10 trending terms featured in Chinese media throughout 2025, including “15th Five-Year ...

Centurion entrepreneur Koketso Ramatlho has won more than R250 000 on Engen The Making Of 2025, securing new funding to ...

Egyptian Foreign Minister Badr Abdelatty has told DW that his country is working to implement a US peace plan for Gaza. His ...

THE Department of Public Works and Highways (DPWH) in Central Visayas has been asked to carry out feasibility studies and ...

Women Empowerment and Economic Development would be a big focus in Telangana Vision Document-2047, which is aimed at ...

New Delhi: The initial public offering (IPO) of pharma firm Corona Remedies, received 62 per cent on the first day of the ...

Ocular intends to submit AXPAXLI New Drug Application (NDA) for wet AMD shortly after year one data from SOL-1, if positive ...

A journey of relentless commitment, Komal Ganotra bridges grassroots activism and policy reform to safeguard children and ...

Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire ...

Mexico's standard workweek will be reduced by two hours annually in coming years to reach 40 hours in 2030, according to a ...